GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

The settlement, which calls for Gilead to pay the U.S. nearly $177 million and the balance to various states, was approved ...

Patients in historically redlined neighborhoods experience significantly longer delays in achieving HIV viral suppression ...

If you support maintaining the U.S. approach to fighting HIV/AIDS, you should welcome the DOGE review to ensure that programs ...

A former top federal health official who served during President Trump’s first term warned that the drastic cuts to the ...

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

Demonstrators gathered Thursday on the steps of the Department of Health and Human Services (HHS) building for a “die-in” ...

The Federal Ministry of Health and Social Welfare, through the National AIDS, Viral Hepatitis and STIs Control Programme ...

The Illinois Department of Public Health has issued a standing order that will allow residents to obtain the HIV preventive ...

A panelist discusses how the HIV patient population has aged significantly, with the average age in their clinic now ...